In support of this, we demonstrated that MeT enhanced the immunogenicity of murine prostate cancer cells leading to elevated T-cell responses in a coculture system, providing in vitro evidence that a viral mimicry response induced by this androgen could modulate the tumor immune microenvironment. This evidence concerns the gene MET and prostate cancer.